Abbott reports positive Simcor trial results

11/4/2007 | CNNMoney

Abbott Laboratories' cholesterol-lowering treatment Simcor significantly reduced "bad" LDL cholesterol and improved "good" HDL cholesterol compared to simvastatin during its Phase III clinical trial. The company hopes to get regulatory approval for Simcor, a combination of simvastatin and another drug from Abbott, during the first quarter of 2008.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health